Association study between clinical response to rizatriptan and some candidate genes

Journal of Headache and Pain

Volumn 8, Issue 3, 2007, Pages 185-189

  Asuni, Carlo ^a   Cherchi, Allesandra ^a   Congiu, Donatella ^a   Piccardi, Maria P ^a   Zompo, Maria ^a   Stochino, Maria E ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dopamine; DRD2; Migraine; Pharmacogenetics; Triptans

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE 2 RECEPTOR; GENOMIC DNA; RIZATRIPTAN; SEROTONIN 1B RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ALLELE; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DRUG RESPONSE; FEMALE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ITALY; MALE; MIGRAINE WITHOUT AURA; PATHOGENESIS; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT OUTCOME;

ADULT; ALLELES; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN AGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TREATMENT OUTCOME; TRIAZOLES; TRYPTAMINES;

EID: 34447308192     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-007-0388-5     Document Type: Article

References (20)

1. Visser WH, Burggraaf J, Muller LM et al (1996) Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. Clin Pharmacol Ther 60:452-460
2. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet 358:1668-1675
3. Waeber C, Moskowitz MA (2003) Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 61[Suppl 4]:S9-S20
4. Maassen VanDenBrink A, Van Den Broek RWM, De Vries R et al (2000) Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology 55:1524-1530
5. Peroutka SJ (1997) Dopamine and migraine. Neurology 49:650-656
6. Peroutka SJ, Wilholt T, Jones K (1997) Clinical susceptibility in migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201-206
7. Del Zompo M, Cherchi A, Palmas MA et al (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781-786
8. Mathew NT, Kailasam J, Gentry P, Chernyshev O (2000) Treatment on nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trials. Headache 40:464-465
9. Sarkar G, Kapelner S, Grandy DK et al (1991) Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11:8-14
10. Arinami T, Gao M, Hamaguchi H, Toru M (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associate with schizophrenia. Hum Mol Genet 6:577-582
11. Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
12. Lappalainen J, Dean M, Charbonneau L et al (1995) Mapping of serotonin 5-HT1D, autoreceptor gene on chromosome 6 and direct analysis for sequence variants. Am J Med Genet 60:157-161
13. Hotamisligil GS, Breakefield XO (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383-392
14. Ott J (1999) Analysis of human genetic linkage. Johns Hopkins University Press, Baltimore
15. Sham PC, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105
16. Maassen VanDenBrink A, Vergouwe MN, Ophoff RA et al (1998) 5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache 38:288-291
17. Maassen VanDenBrink A, Vergouwe MN, Ophoff RA et al (1998) Chromosomal localization of the 5-HT1F receptor gene: No evidence for involvement in response to sumatriptan in migraine patients. Am J Med Genet 77:415-420
18. Ophoff RA, Van Den Maagdenberg A, Roon KI et al (2001) The impact of pharmacogenetics for migraine. Eur J Pharmacol 413:1-10
19. Iadecola C (1998) Neurogenic control of the cerebral circulation: Is dopamine minding the store? Nature Neurosci 1:263-265
20. Basu S, Nagy JA, Pal S et al (2001) The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nature Med 7:569-574